Absci Corporation

Contributing Author

Recent Articles by Absci Corporation

Jul-30	Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 ABSI GlobeNewswire
Jul-24	Absci Announces Pricing of Public Offering of Common Stock ABSI GlobeNewswire
Jul-24	Absci Announces Proposed Public Offering of Common Stock ABSI GlobeNewswire
Jul-07	Absci Appoints Biopharma Leader Mary Szela to Board of Directors ABSI GlobeNewswire
May-20	Absci to Participate in Upcoming Investor Conferences ABSI GlobeNewswire
May-13	Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results ABSI GlobeNewswire
May-13	Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease ABSI GlobeNewswire